SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is under intense scrutiny as it celebrates its 50th anniversary, facing a dual narrative of potential long-term growth through its push into budget-friendly hardware and immediate volatility driven by reported engineering delays on its foldable iPhone and patent infringement setbacks in China. Investors are closely monitoring how the company balances its massive cash reserves against potential settlement costs, while the community remains divided between those bullish on its core ecosystem stability and others wary of its lagging position in the aggressive AI integration race.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant price volatility as investors react to the CMS finalization of a 2027 Medicare Advantage rate hike, which came in stronger than previously feared projections. While some market participants are celebrating this as a major relief rally and a catalyst for a short squeeze, others remain cautious due to ongoing sector-wide regulatory uncertainty and concerns over broader market pressures.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following the formalization of a long-term, multi-year AI chip partnership with Google that extends through 2031, alongside an expanded compute capacity agreement with Anthropic. Investors are actively discussing the stock's role as foundational infrastructure for hyperscale AI deployments, with the market monitoring whether this strategic catalyst can shift sentiment after a period of price consolidation.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is facing significant downward pressure as investors weigh premium valuation concerns and potential macro sensitivity against its role as a key data provider for AI model training. The community is sharply divided, with bulls pointing to the company's long-term data licensing potential and share buyback program, while bears highlight heavy insider selling, concerns over bot-inflated user metrics, and the platform's broader content moderation controversies.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a significant leadership overhaul that replaced CEO Peter Greenleaf with Chairman Kevin Tang, a move that the community widely interprets as a clear signal that the company is being positioned for a potential buyout. Investors are closely monitoring how Tangs new management team will leverage existing assets, such as Lupkynis and the Aritinercept pipeline, to maximize shareholder value.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana and other managed care stocks are surging following a finalized Medicare Advantage payment rate from CMS that exceeded initial market fears and projections. Investors are actively discussing the revenue stability this decision provides for the sector, while others remain focused on navigating volatility and assessing the long-term impacts of policy shifts on insurer margins.

Space and Time is the data blockchain securing onchain finance. Backed by Microsoft’s Venture Fund M12, Space and Time connects real-world data to onchain systems to power tokenized assets, stablecoins, institutional markets, and DeFi.  The SXT token is deployed as an ERC-20 token on Ethereum and functions as the network's native utility token. SXT is used for staking, data processing payments, access control, and incentives for data contributors.

Space and Time

Space and Time (SXT) is gaining significant community traction due to its high-profile technological partnerships, including integrations with Microsoft and Samsung, as well as its focus on verifiable, AI-ready data infrastructure. While some investors are bullish on the project's long-term potential and institutional backing, others are debating the impact of recent token unlocks and questioning its short-term price volatility.

Generac Holdings, Inc. engages in the business of designing and manufacturing energy technology solutions. It operates under the Domestic and International segments. The Domestic segment includes the legacy Generac business and the acquisitions that are based in the United States and Canada. The International segment focuses on Generac business' Latin American export operations. The company was founded in 1959 and is headquartered in Waukesha, WI.

Generac Holdings Inc

Generac is trending due to the intersection of elevated demand for backup power following recent severe hurricane activity and a newly proposed presidential policy to make home generator purchases tax-deductible. The community is actively debating the stock's role as a resilient 'picks and shovels' play in the face of aging grid infrastructure, with some investors eyeing the current volatility as a tactical entry point.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is gaining attention as community members rally behind what they claim is the authentic, original version of the long-standing meme, contrasting it with previous fraudulent copies. Investors are actively discussing its historical roots, its perceived potential as a counter-culture asset, and its ability to maintain relevance in the meme coin landscape.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is in the spotlight as investors await upcoming Phase 2 pediatric trial data for zelicapavir, which the company expects to provide insights into its RSV treatment strategy. Community sentiment remains focused on the potential of Enanta's RSV portfolio and immunology pipeline to address significant unmet market needs despite recent volatility and broader competitive pressures in the biotech sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Morgan Stanley initiated coverage on Duolingo (DUOL) with an 'Overweight' rating and $435 price target on the company's shares, The Fly reported.The vote of confidence from one of Wall Street’s biggest firms sent Duolingo shares up 10% to $370 on Wednesday. With 6.4% gains the previous day, it is the stock's best two-day run since August 2024."We see DUOL as a best-in-class consumer internet asset," Morgan Stanley analysts said in an investor note.They said the language learning app has the "rare combination" of rapid user growth, strong and expanding margins, and a clear generative artificial intelligence upside.The company also has a vast scope for monetization, they said, as it does not run ads, and the current monetization on the platform is about five times below mobile peers.Morgan Stanley also believes Duolingo's market of language learners is far from saturated."With each growth vector magnifying the others we see DUOL as a structural compounder and model a 26% 5-year revenue CAGR," it said.Earlier this month, JPMorgan reiterated Duolingo as its "Best Idea" in the online education sector, citing its strong prospects for user growth and monetization.&nbsp;&nbsp;In other corporate news, Duolingo said this week that it is adding a chess course, which includes the ability to play matches against an AI coach.On Stocktwits, retail sentiment turned to 'extremely bullish' from 'bearish' a day prior, and message volume 'high'.<figure class="image"><img style="aspect-ratio:811/180;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_24_at_8_58_08_AM_png_59cf966d29.webp" alt="Screenshot 2025-04-24 at 8.58.08 AM.png" width="811" height="180"><figcaption>DUOL sentiment and message volume as of April 23 | Source: Stocktwits</figcaption></figure>Several users posted comments suggesting that the backing from Morgan Stanley was a strong buying signal.<stembedurl>https://stocktwits.com/IN0V8/message/612453196</stembedurl><a href="https://stocktwits.com/symbol/DUOL">Shares</a> of Duoling are up over 14% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A laptop keyboard and Duolingo on App Store displayed on a phone screen are seen in this illustration photo. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Duolingo 'Best-In-Class' Internet Stock, Says Morgan Stanley With 'Buy' Call: Retail Sentiment Flips To Extremely Bullish

The investment bank said Duolingo has the rare combination of rapid user growth, strong and expanding margins, and a clear generative artificial intelligence upside.

Equity

The investment bank said Duolingo has the rare combination of rapid user growth, strong and expanding margins, and a clear generative artificial intelligence upside.


Shares of Celsius Holdings Inc. (CELH) soared nearly 36% in after-hours trading Thursday after the energy drinks maker reported a quarterly earnings beat and agreed to acquire Alani Nutrition LLC for $1.8 billion, lifting retail sentiment.The transaction, which includes a mix of cash and stock including a potential $25 million earn-out, will combine “two growing, scaled brands in the U.S. energy drink category,” Celsius said in a statement. The transaction is expected to close in the second quarter of 2025.Founded in 2018, Alani Nu is a growing, female-focused brand that combined with Celsius, is expected to drive about $2 billion in sales.Separately, Celsius Holdings also reported better-than-expected earnings for its fourth quarter."Our record $1.36 billion full-year 2024 revenue reflects a solid year of performance, underscored by consumers' continued preference for our great-tasting, functional products. Celsius achieved exceptional milestones in 2024, which included contributing 30% of all category growth and increasing our category share by 160 basis points to 11.8%,” said John Fieldly, chairman and CEO of Celsius Holdings.Celsius’s Q4 adjusted earnings per share came in at $0.14, surpassing consensus estimates of $0.10, while Q4 revenue stood at $332.2 million, beating expectations of $326.19 million.Sentiment on Stocktwits inched up in the ‘extremely bullish’ zone with commenters cheering the earnings and the deal. Message volumes jumped to the ‘extremely high’ zone.<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_21_at_7_25_06_AM_79eee9c0c2.png" alt="Screenshot 2025-02-21 at 7.25.06 AM.png">One bullish commenter expects Celsius stock to reach $70 on Friday.<stembedurl>https://stocktwits.com/Baskinta1/message/605098008</stembedurl>The acquisition of Alani Nu will further strengthen Celsius' position in the “large, growing global energy category” which is projected to grow at a compounded annual growth rate of 10% from 2024 to 2029, the company noted.It is expected to boost cash EPS in the first year, with projected run-rate cost synergies of $50 million within two years.Retail sales of Alani Nu increased by 78% year-over-year as reported by Circana for the last-four-week period ended Jan. 26, 2025, the company noted. &nbsp;The purchase price for Alani Nu consists of $1.27 billion of cash and a $25 million earn-out and $500 million of newly issued restricted shares of Celsius Holdings common stock, representing about 8.7% pro-forma ownership.The cash payment consists of debt financing of $900 million and about $375 million of cash on hand, according to Celsius.Celsius stock is down 3% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Celsius Holdings Stock Soars On $1.8B Alani Nu Acquisition, Q4 Earnings Beat: Retail’s Exuberant

Sentiment on Stocktwits inched up in the ‘extremely bullish’ zone.

Shares of Celsius Holdings (CELH) slipped more than 5% on Wednesday after brokerage firm TD Cowen downgraded its stock to ‘hold’ from ‘buy,’ dampening retail sentiment.TD Cowen also cut its price target to $29 from $40, Fly.com reported. According to the report, TD Cowen’s retail tracking data showed a decline in the company's sales growth to 0.3% in the last four weeks ending January 11.With Celsius shares well below its highs, valuation multiples could contract further if the company goes "ex-growth," said the report, citing the analyst who warned against heightened competition.Morgan Stanley also highlighted NielsenIQ data that showed Celsius' year-over-year sales dipped in the last two weeks that were assessed, showing a 6% decline in the latest week.Morgan Stanley has kept its ‘Equal Weight’ rating and $42 price target.Sentiment on Stocktwits turned ‘bearish’ from ‘bullish’ a week ago. Message volumes rose to ‘extremely high’ levels from ‘normal.’<img src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_01_23_at_10_23_38_AM_d72c2aed5e.png" alt="Screenshot 2025-01-23 at 10.23.38 AM.png"> Last week, UBS analyst Peter Grom also cut the firm's price target to $39 from $45 with a ‘Buy’ rating, Fly.com reported. According to the analyst, sentiment about consumer staples continues to be bearish despite the sector underperformance compared to the broader market in recent years, with top and bottom line growth for majority of the group has underwhelmed compared to expectations.Celsius is a maker of premium lifestyle energy drinks under its namesake 'Celsisus' brand.Celsius stock is down 3.7% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

(Photo by John Parra/Getty Images for CELSIUS)

Celsius Stock Slips On Analyst Downgrade Amid Rising Competition: Retail Mood Dampens

Sentiment on Stocktwits turned ‘bearish’ from ‘bullish’ a week ago. 

iShares Trust - iShares ESG Select Screened S&P Mid-Cap ETF

Will the U.S. and Iran reach a ceasefire by tomorrow&#39;s deadline?

Stocktwits

Will the U.S. and Iran reach a ceasefire by tomorrow's deadline?

XJH
iShares ESG Screened S&P Mid-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest XJH News

XJHiShares ESG Screened S&P Mid-Cap ETF